216 related articles for article (PubMed ID: 33802855)
1. Chrysophanol Attenuates Manifestations of Immune Bowel Diseases by Regulation of Colorectal Cells and T Cells Activation In Vivo.
Lee HS; Jeong GS
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802855
[TBL] [Abstract][Full Text] [Related]
2. Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-κB and MAPK signaling inactivation.
Dou W; Zhang J; Ren G; Ding L; Sun A; Deng C; Wu X; Wei X; Mani S; Wang Z
Int Immunopharmacol; 2014 Nov; 23(1):170-8. PubMed ID: 25194678
[TBL] [Abstract][Full Text] [Related]
3. 6,7,4'-Trihydroxyflavanone Protects against Dextran Sulfate Sodium-Induced Colitis by Regulating the Activity of T Cells and Colon Cells In Vivo.
Lee HS; Jeong GS
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669855
[TBL] [Abstract][Full Text] [Related]
4. Sarcodon aspratus Extract Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mouse Colon and Mesenteric Lymph Nodes.
Chung MY; Hwang JT; Kim JH; Shon DH; Kim HK
J Food Sci; 2016 May; 81(5):H1301-8. PubMed ID: 27074537
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of tripeptide WLS on TNF-α-induced HT-29 cells and DSS-induced colitis in mice.
Zhou N; Wu N; Yao Y; Chen S; Xu M; Yin Z; Zhao Y; Tu Y
Food Funct; 2022 Sep; 13(18):9496-9512. PubMed ID: 35993870
[TBL] [Abstract][Full Text] [Related]
6. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
7. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
[TBL] [Abstract][Full Text] [Related]
8. Bacterial β-(1,3)-glucan prevents DSS-induced IBD by restoring the reduced population of regulatory T cells.
Lee KH; Park M; Ji KY; Lee HY; Jang JH; Yoon IJ; Oh SS; Kim SM; Jeong YH; Yun CH; Kim MK; Lee IY; Choi HR; Ko KS; Kang HS
Immunobiology; 2014 Oct; 219(10):802-12. PubMed ID: 25092569
[TBL] [Abstract][Full Text] [Related]
9. Strain-Specific Anti-inflammatory Properties of Two
Zhai R; Xue X; Zhang L; Yang X; Zhao L; Zhang C
Front Cell Infect Microbiol; 2019; 9():239. PubMed ID: 31334133
[No Abstract] [Full Text] [Related]
10. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
11. Anti-Inflammatory activity of chrysophanol through the suppression of NF-kappaB/caspase-1 activation in vitro and in vivo.
Kim SJ; Kim MC; Lee BJ; Park DH; Hong SH; Um JY
Molecules; 2010 Sep; 15(9):6436-51. PubMed ID: 20877234
[TBL] [Abstract][Full Text] [Related]
12. Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway.
Fei L; Xu K
J Ethnopharmacol; 2016 Nov; 192():236-247. PubMed ID: 27452656
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol Attenuates Inflammatory Bowel Disease in Mice by Regulating SUMO1.
Wang J; Zhang Z; Fang A; Wu K; Chen X; Wang G; Mao F
Biol Pharm Bull; 2020; 43(3):450-457. PubMed ID: 32115503
[TBL] [Abstract][Full Text] [Related]
14. The anti-inflammatory and immune-modulatory effects of OEA limit DSS-induced colitis in mice.
Lama A; Provensi G; Amoriello R; Pirozzi C; Rani B; Mollica MP; Raso GM; Ballerini C; Meli R; Passani MB
Biomed Pharmacother; 2020 Sep; 129():110368. PubMed ID: 32559625
[TBL] [Abstract][Full Text] [Related]
15. Chrysophanol demonstrates anti-inflammatory properties in LPS-primed RAW 264.7 macrophages through activating PPAR-γ.
Wen Q; Mei L; Ye S; Liu X; Xu Q; Miao J; Du S; Chen D; Li C; Li H
Int Immunopharmacol; 2018 Mar; 56():90-97. PubMed ID: 29367091
[TBL] [Abstract][Full Text] [Related]
16. Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation.
Zhang J; Ding L; Wang B; Ren G; Sun A; Deng C; Wei X; Mani S; Wang Z; Dou W
J Pharmacol Exp Ther; 2015 Feb; 352(2):315-24. PubMed ID: 25472953
[TBL] [Abstract][Full Text] [Related]
17. 6-Gingerol modulates proinflammatory responses in dextran sodium sulfate (DSS)-treated Caco-2 cells and experimental colitis in mice through adenosine monophosphate-activated protein kinase (AMPK) activation.
Chang KW; Kuo CY
Food Funct; 2015 Oct; 6(10):3334-41. PubMed ID: 26263169
[TBL] [Abstract][Full Text] [Related]
18. Stevioside, a diterpenoid glycoside, shows anti-inflammatory property against Dextran Sulphate Sodium-induced ulcerative colitis in mice.
Alavala S; Sangaraju R; Nalban N; Sahu BD; Jerald MK; Kilari EK; Sistla R
Eur J Pharmacol; 2019 Jul; 855():192-201. PubMed ID: 31075241
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease.
Impellizzeri D; Bruschetta G; Di Paola R; Ahmad A; Campolo M; Cuzzocrea S; Esposito E; Navarra M
Clin Nutr; 2015 Dec; 34(6):1146-54. PubMed ID: 25491246
[TBL] [Abstract][Full Text] [Related]
20. Nerolidol Mitigates Colonic Inflammation: An Experimental Study Using both In Vivo and In Vitro Models.
Raj V; Venkataraman B; Almarzooqi S; Chandran S; Ojha SK; Attoub S; Adrian TE; Subramanya SB
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32650602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
